A carregar...
Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma
Immunotherapy drugs are gaining popularity in the treatment of certain malignancies due to the success of these agents in recent clinical trials. Pembrolizumab is an immune checkpoint inhibitor that acts via binding to programmed cell death 1 (PD-1) receptors on T-cells, allowing for the constitutiv...
Na minha lista:
| Publicado no: | J Investig Med High Impact Case Rep |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7448133/ https://ncbi.nlm.nih.gov/pubmed/32830561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709620951339 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|